Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in STIs and SIT

    Project Inform Perspective
    |August 13, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Current HIV treatments cannot eradicate the virus. Structured treatment interruptions (STIs) and structured intermittent therapy (SIT) are being explored as new strategies to manage long-term anti-HIV therapy challenges.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    Everything antiretroviral: 5th IAS conference, Cape Town, South Africa.

    Project Inform perspective·2012
    Same journal

    Well implemented, President Obama's national HIV/AIDS strategy is precisely what is needed to further control HIV/AIDS.

    Project Inform perspective·2011
    Same journal

    Finding health care; preparing for the future.

    Project Inform perspective·2011
    Same journal

    Protecting people with HIV in the California budget.

    Project Inform perspective·2010
    Same journal

    Current drugs in clinical study.

    Project Inform perspective·2010
    Same journal

    HIV treatment information.

    Project Inform perspective·2010
    See all related articles

    Area of Science:

    • HIV/AIDS research
    • Virology
    • Pharmacology

    Background:

    • Current antiretroviral therapies (ART) for HIV are effective at viral suppression but cannot achieve eradication.
    • Long-term ART use presents challenges including side effects, adherence issues, treatment fatigue, and significant lifetime costs.

    Discussion:

    • Structured Treatment Interruptions (STIs) and Structured Intermittent Therapy (SIT) are emerging strategies to address limitations of continuous ART.
    • These intermittent approaches aim to mitigate the cumulative toxicities and reduce the overall burden of lifelong HIV treatment.

    Key Insights:

    • Recognizing the inability of current treatments to eradicate HIV necessitates exploring alternative therapeutic paradigms.
    • Intermittent treatment strategies offer a potential solution to improve patient adherence and reduce long-term treatment-related complications.

    Related Experiment Videos

    Outlook:

    • Further research into the efficacy and safety of STIs and SIT is crucial for their clinical implementation.
    • Developing effective intermittent HIV treatment protocols could revolutionize long-term HIV management and improve patient quality of life.